Skip to main content
Clinical Trials/NCT06267573
NCT06267573Not yet recruitingNot Applicable

Outcomes of Endovascular Repair of Thoracoabdominal Aortic Aneurysms

Assiut University0 sites100 target enrollmentStarted: September 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
100
Primary Endpoint
Successful cannulation of the target vessels with complete in-line flow to target organs.

Study Overview

Brief Summary

Evaluation of the effectiveness of the different modalities for treatment of thoracoabdominal aortic aneurysms. FEVAR and BEVAR devices are widely used now due to its feasability and wide range of use . We aim to evaluate the effectiveness of these new devices in the management of TAAA

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • all adult consecutive patients presenting with TAAA larger than 5.5 cm

Exclusion Criteria

  • active infection Asymptomatic patients with small aneurysms Allergy to contrast agents

Outcomes

Primary Outcomes

Successful cannulation of the target vessels with complete in-line flow to target organs.

Time Frame: Two years

No ischemia

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kerolos Raafat Khalil Gad

Assistant lecturer

Assiut University

Similar Trials

Thoracoabdominal Aortic Aneurysms | Clinical Trial